Paolo Fusar-Poli, M.D. Ph.D.
Affiliations: | Institute of Psychiatry at the Maudsley | King's College London, London, UK |
Area:
First episode of psychosis, fMRI, MRIGoogle:
"Paolo Fusar-Poli"Mean distance: 16029.9
Children
Sign in to add traineeCathy Davies | grad student | King's College | |
Joaquim Radua | post-doc | Institute of Psychiatry at the Maudsley, Kings College London |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Brodeur S, Oliver D, Ahmed MS, et al. (2024) Why we need to pursue both universal and targeted prevention to reduce the incidence of affective and psychotic disorders: systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews. 105669 |
Livingston NR, De Micheli A, McCutcheon RA, et al. (2024) Effects of Benzodiazepine Exposure on Real-World Clinical Outcomes in Individuals at Clinical High Risk for Psychosis. Schizophrenia Bulletin |
De Micheli A, Provenzani U, Krakowski K, et al. (2024) Physical Health and Transition to Psychosis in People at Clinical High Risk. Biomedicines. 12 |
Oliver D, Arribas M, Perry BI, et al. (2024) USING ELECTRONIC HEALTH RECORDS TO FACILITATE PRECISION PSYCHIATRY. Biological Psychiatry |
Zhu Y, Maikusa N, Radua J, et al. (2024) Using brain structural neuroimaging measures to predict psychosis onset for individuals at clinical high-risk. Molecular Psychiatry |
Choi H, Kim JH, Yang HS, et al. (2024) Pharmacological and non-pharmacological interventions for irritability in autism spectrum disorder: a systematic review and meta-analysis with the GRADE assessment. Molecular Autism. 15: 7 |
Davies C, Martins D, Dipasquale O, et al. (2024) Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin. Molecular Psychiatry |
Efthimiou O, Taipale H, Radua J, et al. (2024) Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data. The Lancet. Psychiatry. 11: 102-111 |
Catalan A, McCutcheon RA, Aymerich C, et al. (2024) The magnitude and variability of neurocognitive performance in first-episode psychosis: a systematic review and meta-analysis of longitudinal studies. Translational Psychiatry. 14: 15 |
Patel R, Brinn A, Irving J, et al. (2023) Oral and long-acting injectable antipsychotic discontinuation and relationship to side effects in people with first episode psychosis: a longitudinal analysis of electronic health record data. Therapeutic Advances in Psychopharmacology. 13: 20451253231211575 |